Sterling Private Medical’s advertised GLP-1 prices are easy to find; the full financial commitment takes more work to understand. Its website promotes monthly packages combining medication, supplies, provider care and concierge support. Yet the amounts are starting prices, confirmed after consultation, while the terms authorize an immediate charge and recurring charges every 30 days. For someone comparing household expenses, the important number is therefore not just the figure on the program card: it is the individualized amount, collection date and cancellation rule attached to enrollment.
This documentary review examines Sterling’s own pages and terms, consulted October 19, 2026, alongside federal clinical guidance. Sterling documents a GLP-1 telehealth offering involving compounded medications, but its marketing description of a private medical practice differs from its contractual role as an intermediary for independent clinicians and pharmacies. That distinction matters when asking who provides care, fills a prescription or resolves a billing problem. The strongest reason to pause before paying is a separate discrepancy: treatment pages require 30 days’ cancellation notice, while the terms describe a 48-hour cutoff.
At a glance
- Advertised injection prices
- Semaglutide injection starts at $169 per month; tirzepatide injection starts at $199 per month. Both advertise medication and supplies, with final pricing confirmed after consultation.Sources: [5]
- Microdose price and missing specifications
- GLP-1 Microdose starts at $129 per month with medication and supplies included, but the consulted material does not identify its active ingredient or route.
- Recurring collection
- The terms authorize an immediate charge and another every 30 days until cancellation, with electronic notice five to seven days before a scheduled transaction.Sources: [9]
- Cancellation discrepancy
- Treatment pages specify 30 days’ notice before the next billing cycle; the terms allow turning off auto-refill at least 48 hours before monthly processing.
- Who supplies the service
- Sterling’s terms describe a platform that bundles pharmacy, medical-group and platform fees, not an entity that itself provides clinical care or prepares or dispenses medication.Sources: [9]
Read the starting prices as an invitation to obtain a quote
Sterling presents three GLP-1 options: semaglutide injection from $169 per month, tirzepatide injection from $199 per month and GLP-1 Microdose from $129 per month. Each program card advertises a physician-directed protocol, medication and supplies, discreet home delivery, and round-the-clock concierge care and check-ins. Those are substantial advertised inclusions, but “from” remains a material qualification. The homepage says the final price is confirmed after consultation; it does not establish that every accepted patient pays the lowest displayed amount.
The consulted material does not explain which circumstances raise the final quote above those starting amounts. Nor does it identify the active ingredient or route for the microdose program. That makes the $129 listing a less complete product description than the two explicitly injectable offerings. No distinct introductory promotion or subsequent renewal price is documented here. Rather than assuming either a permanent rate or a scheduled increase, ask for the quoted medication, formulation, route, supplied quantity and recurring charge together.
The table separates what is advertised from what still needs clarification. It should not be read as a comparison of equivalent products or a treatment recommendation. Our guide to understanding the first GLP-1 payment explains why the amount due at enrollment deserves its own confirmation, even when a provider promotes a straightforward monthly package.
| Offering or term | Documented price or inclusion | Clarification before payment |
|---|---|---|
| Semaglutide injection | From $169 per month; medication and supplies included | Individual quote, formulation and quantity supplied |
| Tirzepatide injection | From $199 per month; medication and supplies included | Individual quote, formulation and quantity supplied |
| GLP-1 Microdose | From $129 per month; medication and supplies included | Active ingredient, route and exact presentation |
| Monthly package | Medication, provider care and concierge support advertised | Whether testing, labs or in-person care cost extra |
| Recurring order | Immediate charge, then every 30 days | First collection amount and applicable cancellation deadline |
The bundle has three payees, even if the patient sees one price
Sterling markets its membership as a single monthly price without insurance required. Its semaglutide page goes further, advertising no consultation charges and no dose-change surcharges. These statements provide more useful cost information than a bare medication price would. Nevertheless, the consulted documents do not settle whether laboratory work, other testing or in-person care is included. They also do not document insurance reimbursement arrangements. A self-pay presentation should not be mistaken for a promise that a health plan will repay the expense.
The terms explain the underlying payment structure: the subscription bundles the pharmacy’s drug fee, the medical group’s provider-service fee and Sterling’s platform-access fee. Sterling collects the pharmacy and medical-group portions on their behalf. This supports the advertised one-payment model, but it also identifies different service responsibilities within the package. Ask who will issue the receipt, answer a disputed-charge question and explain any service outside the bundle before assuming all future care has been prepaid.
No separate shipping charge is specified in the consulted evidence, but that absence is not an explicit free-shipping guarantee. Likewise, included supplies do not establish exactly which items or quantities arrive. A written list is more useful than relying on the phrase “no hidden fees.” The guide to included GLP-1 costs offers a framework for distinguishing named inclusions from expenses a program has not addressed.
“Monthly” billing means every 30 days under the terms
For a recurring monthly order, Sterling’s terms authorize collection immediately and every 30 days afterward until cancellation. They also promise an electronic notification five to seven days before a scheduled transaction and a receipt after a successful charge. A 30-day interval is not the same as charging on a fixed calendar date each month, and it is not a four-week interval. For budgeting, the processing schedule matters independently of the price shown on the homepage.
The immediate-charge language and consultation-confirmed pricing leave an important sequencing question: when will the individualized amount be shown, accepted and collected? The supplied documents do not establish the complete checkout sequence or a specific refund outcome if a clinician declines to prescribe. They do establish that a prescription requires consultation, a provider’s determination that the product is appropriate and an issued prescription. Paying or completing an assessment therefore should not be treated as a guarantee of medication.
There is no documented package duration, supply quantity or minimum commitment that can safely be inferred from the monthly label alone. Nor does a billing interval establish how long a particular shipment lasts. Before authorizing recurring collection, request the first charge date, next processing date and expected supply duration separately. Our explanation of monthly and four-week billing helps keep those different clocks from being collapsed into one.
Resolve cancellation before the first renewal becomes imminent
Sterling’s cancellation language is not consistent across the consulted documents. The treatment page says memberships may be canceled with 30 days’ notice before the next billing cycle. The terms instead say a subscription can be canceled by turning off auto-refill in the user portal at least 48 hours before the applicable monthly processing date. These are materially different deadlines. This review cannot determine which Sterling would apply to a particular enrollment, and neither should be silently substituted for the other.
The promised transaction reminder does not solve that discrepancy. A notice arriving five to seven days before collection would precede the contractual 48-hour cutoff, but would arrive after a 30-day notice deadline for that same collection. Obtain written confirmation of the applicable rule while there is still time to act. Also ask what event makes an order noncancelable: payment processing, clinical service, pharmacy processing or another milestone. The supplied material does not resolve all those operational boundaries.
Refunds are a separate issue. The treatment page says consultations, medical visits and fulfilled prescriptions are nonrefundable once services begin or medication is processed. That wording matters even though consultation charges are advertised as included rather than separately billed. Stopping renewal does not automatically reverse an existing payment. The cancellation and refund guide explains this distinction; for Sterling, preserving the written cancellation confirmation and processing date is particularly useful because the published deadlines conflict.
Know which organization owes you which part of the service
Sterling describes itself publicly as a private concierge telehealth practice for weight, hormones and healthy aging, serving men and women. It also advertises hormone optimization, with GLP-1 programs booked online and other services arranged directly with a physician. Its legal description is narrower: a platform facilitating access to independent clinicians and compounding pharmacies. Claims that those clinicians are U.S. board-certified and pharmacies state-licensed are the site’s representations, not credentials independently verified for this review.
The terms expressly say Sterling does not practice medicine, provide clinical care, prepare or dispense drugs, or control clinicians’ and pharmacies’ professional judgment. Enrollment requires a registered account. The advertised process starts with an online assessment of goals and basic medical history, followed by a licensed clinician’s review and a plan if appropriate. The consulted sample does not name the individual clinicians, medical groups or dispensing pharmacies. Requesting those identities helps clarify responsibility before money changes hands.
State availability also needs confirmation. Although Sterling promotes nationwide coverage, its terms make service subject to state-specific rules and possible changes. They require patients to be physically in the same state as the account’s shipping address during a consultation. Users must be at least 18, or the local age of majority if higher. An advertised national footprint is therefore not confirmation that a particular medication can be prescribed and shipped for every address or travel situation.
Pharmacy choice and delivery are part of the purchase
Sterling’s semaglutide page describes compounded medication prepared by partner pharmacies in the United States and shipped on a structured cadence. It advertises temperature-controlled, unmarked packaging delivered to the home. However, the consulted documents do not specify the amount supplied per shipment, precise preparation or dispatch timelines, or an arrival window. The terms also require buyers of prescription-inclusive services to accept fulfillment through a platform-accessible pharmacy and waive choosing another pharmacy; those unwilling to do so are told not to purchase.
Another concrete term concerns packaging: prescriptions will not be dispensed in child-resistant containers. That is relevant to household planning, not merely a shipping detail. Sterling advertises structured follow-up reviews and around-the-clock portal messaging, but those features do not establish a guaranteed clinical response or delivery time. FDA advises not using an injectable GLP-1 drug that arrives warm or insufficiently refrigerated and contacting the provider or dispensing pharmacy. A delivery problem therefore needs a clinical or pharmacy resolution, not just a tracking update.
A lower advertised price does not answer the clinical questions
Sterling acknowledges that compounded medications are not FDA approved and says customized formulations may be prescribed when commercially available treatments do not meet individual needs. FDA likewise recommends compounded drugs when an individual’s medical needs cannot be met by an approved drug, with a prescription and a state-licensed pharmacy. Compounded preparations do not undergo FDA premarket review for safety, effectiveness and quality. That distinction does not, by itself, demonstrate clinical inequivalence or establish that Sterling’s products are effective or ineffective.
The semaglutide and tirzepatide pages describe candidates as adults 18 or older with BMI at least 27, or at least 25 with weight-related conditions. These are Sterling’s published criteria, not individualized eligibility advice. Its semaglutide exclusions include personal or family history of medullary thyroid carcinoma or MEN 2, pregnancy, breastfeeding or planned pregnancy, active pancreatitis and untreated severe gastrointestinal disease. The site says its BMI calculator is educational and that a licensed provider decides eligibility.
For microdosing, Sterling describes audiences including people near goal weight, those who poorly tolerated standard GLP-1 treatment and people incorporating it into a hormone or healthy-aging plan. These are provider descriptions, not established outcomes for the offered preparation. Research on specific studied medicines does not establish results for Sterling’s compounded products or microdose program. Because the microdose ingredient and route are unspecified here, its price alone is especially inadequate as a basis for comparing treatment value.
Test the concierge promise with practical service questions
Sterling lists support@sterlingprivatemedical.com, (475) 290-6731 and secure messaging available 24/7. Its contact form promises a team response within 24 hours. These are useful contact paths, but the form-response promise is not a documented clinician-review deadline, pharmacy turnaround or guarantee of immediate medical access. Before enrolling, ask how billing questions, medication concerns and requests for clinical review are routed. Also ask about laboratory expenses and follow-up scheduling, which the consulted material does not fully specify.
Privacy deserves a similarly document-specific reading. The semaglutide page says medical information is shared only with the physician and dispensing pharmacy and broadly promises never to sell or share data. The California notice, however, describes advertising-related disclosures of personal information that may count as a sale or sharing under California law. The terms say Sterling is not a HIPAA-covered entity, although it may sometimes act as a business associate. These documents address different data categories, so the broad marketing assurance should not substitute for reviewing the applicable notices.
Questions & answers
Is Sterling’s $169 semaglutide price guaranteed for everyone?
No. Sterling advertises semaglutide injection from $169 per month and says final pricing is confirmed after consultation. Medication and supplies are advertised as included, along with provider care and concierge support in the monthly package. The consulted evidence does not explain what determines a higher individualized price. Obtain the final amount and product details before authorizing recurring payment.
Does Sterling bill once per calendar month?
The recurring-order terms specify an immediate charge and subsequent charges every 30 days, not a fixed calendar-month date. They promise electronic notice five to seven days before a scheduled transaction. Ask for your actual processing dates and expected medication supply duration; the billing interval alone does not establish the quantity shipped or how long it lasts.
How do I cancel a Sterling subscription?
The terms describe turning off auto-refill in the user portal at least 48 hours before monthly processing. The treatment page instead requires 30 days’ notice before the next cycle. Because that difference remains unresolved, obtain written clarification rather than assuming the shorter deadline governs. Cancellation also does not establish refund eligibility for services already begun or medication already processed.
Can I use my own pharmacy through Sterling?
The terms say purchasing a prescription-inclusive service requires accepting fulfillment through a pharmacy accessible through the platform and waiving pharmacy choice. They advise against purchasing if you do not accept that condition. The consulted sample does not identify the dispensing pharmacies by name, so request the pharmacy’s identity and contact information before enrollment if that affects your decision.
What exactly is in Sterling’s $129 microdose program?
Sterling advertises GLP-1 Microdose from $129 per month, including medication and supplies, delivery and concierge support. The consulted material does not identify its active ingredient or route. It describes intended audiences, including people near goal weight and those who poorly tolerated standard GLP-1 treatment, but that description does not establish suitability or results. Request a precise product description and clinician explanation.
Does Sterling’s 24/7 messaging mean immediate clinician access?
Not necessarily. Sterling advertises around-the-clock portal messaging and separately promises a team reply to contact-form submissions within 24 hours. Neither statement specifies immediate clinician review, prescribing or pharmacy dispatch. Ask who monitors each channel and what response window applies to clinical concerns. Published support contacts are support@sterlingprivatemedical.com and (475) 290-6731; those contact options do not establish emergency-care capability.
Our assessment
Sterling provides useful starting prices and a relatively clear advertised bundle: medication, supplies, provider care and concierge support, with no consultation or dose-change surcharges stated on its semaglutide page. Its terms also explain the three-part payment structure and 30-day collection interval. Those disclosures make an initial comparison possible, but not a complete budget. The unresolved cancellation deadlines are the most immediate financial concern, followed by unspecified final-price conditions, shipment quantities, testing costs and microdose product details. A practical next step is a written quote naming the product, responsible clinician and pharmacy, first and recurring charges, supplied quantity and controlling cancellation rule. Sterling may offer the convenience its concierge model advertises, but the consulted documentation does not establish clinical performance, immediate access or universal state availability. Judge the package by those written specifics rather than the lowest displayed monthly price.
This opens the reviewed business’s website. The link is not a prescription or endorsement. Commercial relationships.
Sources & documentation
Public materials consulted October 19, 2026. Provider statements are attributed claims, not independently verified clinical outcomes. Terms can change; obtain a current written quote.
- FDA concerns with unapproved GLP-1 drugs used for weight loss ↗
- Wilding et al. (2021): STEP 1 semaglutide trial ↗
- Jastreboff et al. (2022): SURMOUNT-1 tirzepatide trial ↗
- Sterling Private Medical — treatments/semaglutide ↗
- Sterling Private Medical — official website ↗
- Sterling Private Medical — about ↗
- Sterling Private Medical — contact ↗
- Sterling Private Medical — privacy ↗
- Sterling Private Medical — terms ↗
- Sterling Private Medical — treatments/tirzepatide ↗
- Sterling Private Medical — treatments/glp 1 microdose ↗